首页> 外文期刊>Medical dosimetry: official journal of the American Association of Medical Dosimetrists >Functional image-guided stereotactic body radiation therapy planning for patients with hepatocellular carcinoma
【24h】

Functional image-guided stereotactic body radiation therapy planning for patients with hepatocellular carcinoma

机译:肝细胞癌患者的功能性图像引导的立体定向体辐射治疗计划

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of the current planning study is to evaluate the ability of gadoxetate disodium-enhanced magnetic resonance imaging (EOB-MRI)-guided stereotactic body radiation therapy (SBRT) planning by using intensity-modulated radiation therapy (IMRT) techniques in sparing the functional liver tissues during SBRT for hepatocellular carcinoma. In this study, 20 patients with hepatocellular carcinoma were enrolled. Functional liver tissues were defined according to quantitative liver-spleen contrast ratios >= 1.5 on a hepatobiliary phase scan. Functional images were fused with the planning computed tomography (CT) images; the following 2 SBRT plans were designed using a "step-and-shoot" static IMRT technique for each patient: (1) an anatomical SBRT plan optimization based on the total liver; and (2) a functional SBRT plan based on the functional liver. The total prescribed dose was 48 gray (Gy) in 4 fractions. Dosimetric parameters, including dose to 95% of the planning target volume (PTV D-95%), percentages of total and functional liver volumes, which received doses from 5 to 30 Gy (V5 to V30 and fV5 to fV30), and mean doses to total and functional liver (MLD and fMLD, respectively) of the 2 plans were compared. Compared with anatomical plans, functional image-guided SBRT plans reduced MLD (mean: plan A, 5.5 Gy; and plan F, 5.1 Gy; p < 0.0001) and fMLD (mean: plan A, 5.4 Gy; and plan F, 4.9 Gy; p < 0.0001), as well as V5 to V30 and fV5 to fV30. No differences were noted in PTV coverage and nonhepatic organs at risk (OARs) doses. In conclusion, EOB-MRI-guided SBRT planning using the IMRT technique may preserve functional liver tissues in patients with hepatocellular carcinoma (HCC). (C) 2017 American Association of Medical Dosimetrists.
机译:目前的计划研究的目的是评估钆分解增强磁共振成像(EoB-MRI) - 术立体定向体放射治疗(SBRT)规划的能力,采用强度调制的放射治疗(IMRT)技术备用功能肝细胞癌SBRT期间的肝组织。在本研究中,注册了20例肝细胞癌患者。在肝胆相扫描上根据定量肝脏对比度测定,根据定量肝脏对比度测定来定义功能性肝组织。功能图像与规划计算机断层扫描(CT)图像融合;以下2 SBRT计划使用每位患者的“阶梯和拍摄”静态IMRT技术设计:(1)基于总肝脏的解剖学SBRT计划优化; (2)基于功能性肝脏的功能性SBRT计划。在4个级分中,规定的剂量总量为48灰(GY)。剂量测定参数,包括95%的计划目标体积(PTV D-95%),总和功能性肝体积的百分比,从5至30Gy(V5至V30和Fv5至Fv30)接受剂量,以及平均剂量比较了2个计划的总和功能性肝脏(MLD和FMLD)。与解剖结构相比,功能性图像引导的SBRT计划减少了MLD(平均值:计划A,5.5 Gy;和计划F,5.1 Gy; P <0.0001)和FMLD(平均:计划A,5.4 GY;和计划F,4.9 GY ; P <0.0001),以及V5至V30和FV5至FV30。在PTV覆盖范围内没有差异,风险(OAR)剂量的非肝剂器官。总之,使用IMRT技术的EoB-MRI引导的SBRT计划可以保护肝细胞癌(HCC)患者的功能性肝组织。 (c)2017年美国医疗剂量分子协会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号